REGENXBIO, Inc. (RGNX)
6.125
+0.04
(+0.74%)
USD |
NASDAQ |
Jun 08, 16:00
6.125
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Shareholders Equity (Quarterly) : 21.08M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ocugen, Inc. | 5.805M |
| Capricor Therapeutics, Inc. | 278.70M |
| Krystal Biotech, Inc. | 1.277B |
| Biogen, Inc. | 18.65B |
| AbbVie, Inc. | -6.656B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 341.89M |
| Total Liabilities (Quarterly) | 320.81M |
| Debt to Equity Ratio | 11.78 |
| Current Ratio | 2.623 |
| Net Debt Paydown Yield | -4.93% |